title: Treating MERS-CoV during an outbreak.
authors.affiliation: Department of Microbiology and Immunology, University of Maryland at Baltimore, Baltimore, MD 21201, USA.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Coleman
authors.affiliation: Department of Microbiology and Immunology, University of Maryland at Baltimore, Baltimore, MD 21201, USA. Electronic address: mfrieman@som.umaryland.edu.
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Frieman
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D018352:Coronavirus Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D065207:Middle East Respiratory Syndrome Coronavirus / Q000187:drug effects*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin